Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by TOONER77on May 02, 2021 11:19am
322 Views
Post# 33110597

TLRY vote

TLRY vote

DJ Tilray Shareholders Approve Aphria Merger, Creating World's Biggest Cannabis Company By Revenue -- MarketWatch

Sunday, May 2, 2021, 10:36 AM ET
 

Tilray Inc. (TLRY) shareholders voted to approve the Canadian cannabis company's proposed merger with Aphria Inc. (APHA.T) at a special meeting on Friday, according to media reports, paving the way for the creation of the world's biggest cannabis company measured by revenue. The move was widely expected after Aphria shareholders voted in favor of a deal by a wide margin, with a total of 99.38% of shares voted approving it on April 14. The deal is expected to close in the second quarter. Under the terms of the proposed deal, Aphria shareholders will receive 0.8381 of a Tilray share of class 2 common stock for each Aphria share owned. Tilray changed its bylaws in April (https://www.marketwatch.com/story/aphria-and-tilray-cannabis-merger-moves-a-step-closer-to-approval-11618594687)to reduce its shareholder vote quorum to one-third of the voting power of the outstanding shares entitled to vote to approve the deal, instead of a majority of the voting power of the outstanding shares. That move was also expected to make it easier for the deal to be approved. Tilray shares closed Friday down 1.78%, but have gained 122% in the year to date. Aphria shares closed down 0.5% and are also up 122% year-to-date. The Cannabis ETF (THCX) has gained 47% and the S&P 500 has gained 9%.

-Ciara Linnane
 For more from MarketWatch: https://www.marketwatch.com/newsviewer 

<< Previous
Bullboard Posts
Next >>